Amoxycillin and Potassium Clavulanate 625mg (4:1 ratio) represents one of the most widely prescribed broad-spectrum antimicrobial combinations in inpatient and outpatient clinical practice.
1. Mechanism of Beta-Lactamase Inhibition
Potassium Clavulanate acts as a suicide inhibitor of bacterial beta-lactamase enzymes, safeguarding Amoxycillin from enzymatic degradation and restoring its bactericidal activity against resistant pathogens.
2. ALU-ALU Packaging & Moisture Sensitivity
Clavulanic acid is intensely hygroscopic and decomposes rapidly when exposed to humidity. Cold-form ALU-ALU packaging creates a hermetic barrier protecting chemical assay stability over its 24-month shelf life.
3. Hospital Sourcing & Institutional Formulations
Riomedica supplies RIOMOX-CV 625 tablets in standardized 10x1x10 and 10x10 ALU-ALU packaging accompanied by batch COAs confirming bioequivalent disintegration and chemical purity.
Partner with Riomedica Healthcare Pvt. Ltd.
Winner of the Indian Icon Award 2026. Certified WHO-GMP & ISO 9001:2015 pharmaceutical manufacturer offering 715+ formulations with guaranteed quality, prompt dispatch, and dedicated institutional procurement support across India.
